Arshian Hussnain Medical Clinic
Lahore, Punjab Province, 6400, Pakistan
Location status: Recruiting
Location contact
Fizza Tahir, MSPT(WH)
PRINCIPAL_INVESTIGATOR
sobia ghafoor, MSPT-OM
CONTACT
NCT Number: NCT07576205
The aim of this study is to compare the combined effects of Paula method & tibial nerve stimulation on incontinence, pelvic floor muscles strength, sexual function and quality of life in stress urinary incontinence
Interested in participating?
Request Info30 year–45 year
Female
Interventional
Not applicable
Lahore, Punjab Province, 6400, Pakistan
Location status: Recruiting
Fizza Tahir, MSPT(WH)
PRINCIPAL_INVESTIGATOR
sobia ghafoor, MSPT-OM
CONTACT
This study will be randomized controlled trial and will be conducted in Arshian Hussnain Medical Clinic and at Marie Stopes Society. Non probability convenience sampling technique will be used and 56 participants will be recruited in study after randomization. Inclusion criteria will be females aged 30-45 years, multiparous women (≥2 full-term vaginal delivery). Exclusion criteria will be Neurological disorders, pregnancy and dermatological conditions .The subjects will be divided into two groups. Group A will receive Paula exercise and Tibial nerve stimulation. Group B will receive only Paula exercises. Both groups will receive baseline treatment which will include pelvic floor muscle contractions. The total duration of treatment will be 8 weeks and there will be 2 sessions each week. Outcomes assessed will be urinary function, pelvic floor muscles strength, sexual function & quality of life. Outcomes will be assessed using validated tools such as the IIQ-7, Modified Oxford Scale, FSFI, and SF-36. After data collection, it will be analyzed by using SPSS version 21.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 8th week
The Incontinence Impact Questionnaire (IIQ-7) is a brief, 7-item instrument used to assess the impact of urinary incontinence on a woman's quality of life.
Time frame: 8th week
The Modified Oxford Scale is a clinical tool used to assess the strength of pelvic floor muscles through vaginal or rectal examination. It uses a 6-point scale (0 to 5), where 0 indicates no contraction and 5 represents a strong contraction. A Cronbach's alpha is not typically reported for this scale because it is based on a single-item, ordinal rating by a clinician, rather than a multi-item questionnaire
Time frame: 8th week
The Female Sexual Function Index (FSFI) is a 19-item self-report questionnaire designed to assess six domains of female sexual function: desire, arousal, lubrication, orgasm, satisfaction, and pain. Each domain is scored individually and contributes to a total score that reflects overall sexual function, with higher scores indicating better function
Time frame: 8th week
The Short Form-36 Health Survey (SF-36) is a widely used 36-item questionnaire designed to measure health-related quality of life across eight domainsThese domains contribute to two summary scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS).
Contact information is provided by the study sponsor or research team.
Riphah International University
Other
Combine Effects of Paula Exercises and Tibial Nerve Stimulation on Incontinence, Pelvic Floor Muscles Strength, Sexual Function and Quality of Life in Stress Urinary Incontinence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04248283
Behavior, Behavioral Symptoms
Denver, Colorado, United States
View Trial DetailsNCT06480227
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
La Jolla, California, United States
View Trial DetailsNCT06369922
Acute Pain, Female Urogenital Diseases
Rochester, New York, United States
View Trial DetailsNCT07520396
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Lahore, Punjab Province, Pakistan
View Trial Details